Skip to main content
SpringerLink
Log in

Depression, Angst und Schlafstörungen – wichtige Komorbiditäten der Neuropathie

Depression, anxiety and sleep disorders – significant comorbidities of neuropathy

  • Leitthema
  • Published:
Der Diabetologe Aims and scope

Zusammenfassung

Die diabetische Neuropathie ist sehr häufig mit Depressionen, Angststörungen und auch Schlafstörungen assoziiert. Für die Prognose der Erkrankung wie auch die Lebensqualität des Patienten hat diese Trias summativ einen negativen Einfluss. In der Praxis sollte daher standardmäßig bei Neuropathiepatienten ein Screening in Bezug auf Depressionen, Angststörungen und Schlafstörungen erfolgen. Entsprechende diagnostische Instrumente werden in dem Beitrag dargestellt. Mit NEUROS steht erstmals ein patientengerechtes Schulungs- und Behandlungsprogramm für die klinische Praxis zur Verfügung, das gleichermaßen auf ein verbessertes Therapieverhalten, eine bessere Krankheitsbewältigung wie auch den Erhalt der Lebensqualität und Prophylaxe von psychischen Problemen im Zusammenhang mit der Neuropathie abzielt.

Abstract

Diabetic neuropathy is highly associated with depression, anxiety disorders and sleep impairment. Summatively, this triad has a strong negative impact on the prognosis of diabetes as well as quality of life. Therefore, screening for depression, anxiety and sleep disturbance should be standard in clinical practice. Appropriate diagnostic tools are presented in this article. “NEUROS” provides a new, patient-orientated education and treatment program, aiming in equal measure at improved self-management and ability to cope with the disease, maintenance of quality of life and prevention of psychological problems associated with diabetic neuropathy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1
Abb. 2
Abb. 3
Abb. 4
Abb. 5

Literatur

  1. Ziegler D (2008) Treatment of diabetic neuropathy and neuropathic pain: how far have we come? Diabetes Care 31 (Suppl 2):255–261

    Article  Google Scholar 

  2. Herder C, Lankisch M, Ziegler D et al (2009) Subclinical inflammation and diabetic polyneuropathy: MONICA/KORA Survey F3 (Augsburg, Germany). Diabetes Care 32(4):680–682

    Article  PubMed  Google Scholar 

  3. Kulzer B, Stark S, Hermanns N, Haak T (2009) Zusammenhang zwischen neuropathisch bedingten Defiziten, Schmerz-/Missempfindungssymptomatik und diabetesbezogenen Belastungen. Diabetol Stoffw 4 (Suppl 1):56

    Google Scholar 

  4. Gore M, Brandenburg NA, Hoffman DL et al (2006) Burden of illness in painful diabetic peripheral neuropathy: the patients‘ perspectives. J Pain 7(12):892–900

    Article  PubMed  Google Scholar 

  5. Barrett AM, Lucero MA, Le T et al (2007) Epidemiology, public health burden and treatment of diabetic peripheral neuropathic pain: a review. Pain Med 8 (Suppl 2):S50–S62

    Article  PubMed  Google Scholar 

  6. Argoff CE, Cole BE, Fishbain DA, Irving GA (2006) Diabetic peripheral neuropathic pain: clinical and quality-of-life issues. Mayo Clin Proc 81 (Suppl 4):S3–S11

    PubMed  Google Scholar 

  7. Zelman DC, Brandenburg NA, Gore M (2006) Sleep impairment in patients with painful diabetic peripheral neuropathy. Clin J Pain 22(8):681–685

    Article  PubMed  Google Scholar 

  8. Tolle T, Xu X, Sadosky AB (2006) Painful diabetic neuropathy: a cross-sectional survey of health state impairment and treatment patterns. J Diabetes Complications 20(1):26–33

    Article  PubMed  Google Scholar 

  9. Moreira RO, Papelbaum M, Fontenelle LF et al (2007) Comorbidity of psychiatric disorders and symmetric distal polyneuropathy among type II diabetic outpatients. Braz J Med Biol Res 40(2):269–275

    PubMed  CAS  Google Scholar 

  10. Anderson RJ, Freedland KE, Clouse RE, Lustman PJ (2001) The prevalence of comorbid depression in adults with diabetes: A meta-analysis. Diabetes Care 24(6):1069–1078

    Article  PubMed  CAS  Google Scholar 

  11. Hermanns N, Kulzer B, Krichbaum M et al (2005) Affective and anxiety disorders in a German sample of diabetic patients: prevalence, comorbidity and risk factors. Diabet Med 22(3):293–300

    Article  PubMed  CAS  Google Scholar 

  12. Kruse J, Schmitz N, Thefeld W (2003) On the association between diabetes and mental disorders in a community sample. Diabetes Care 26:1841–1846

    Article  PubMed  Google Scholar 

  13. Pouwer F, Beekman ATF, Nijpels G et al (2003) Rates and risks for co-morbid depression in patients with type 2 diabetes mellitus: results of a community based study. Diabetologia 46:892–898

    Article  PubMed  CAS  Google Scholar 

  14. Groot M de, Anderson RJ, Freedland KE et al (2001) Association of depression and diabetes complications: A meta-analysis. Psychosom Med 63:619–630

    PubMed  Google Scholar 

  15. Kulzer B, Hermanns N, Stark S, Haak T (2007) Quality of life in patients with diabetic neuropathy. Diabetes 56 (Suppl 1):A497–A498

    Google Scholar 

  16. Vileikyte L, Leventhal H, Gonzalez JS et al (2005) Diabetic peripheral neuropathy and depressive symptoms: the association revisited. Diabetes Care 28(10):2378–2383

    Article  PubMed  Google Scholar 

  17. Vileikyte L, Peyrot M, Gonzalez JS et al (2009) Predictors of depressive symptoms in persons with diabetic peripheral neuropathy: a longitudinal study. Diabetologia 52 [Epub Apri 18]

  18. Black SA, Markides KS, Ray LA (2003) Depression predicts increased incidence of adverse health outcomes in older mexican americans with type 2 diabetes. Diabetes Care 26(10):2822–2828

    Article  PubMed  Google Scholar 

  19. Egede LE (2004) Diabetes, major depression and functional disability among U.S. adults. Diabetes Care 27(2):421–428

    Article  PubMed  Google Scholar 

  20. Egede LE, Nietert PJ, Zheng D (2005) Depression and all-cause and coronary heart disease mortality among adults with and without diabetes. Diabetes Care 28(6):1339–1345

    Article  PubMed  Google Scholar 

  21. Zhang X, Norris SL, Gregg EW et al (2005) Depressive symptoms and mortality among persons with and without diabetes. Am J Epidemiol 161(7):652–660

    Article  PubMed  Google Scholar 

  22. Katon WJ, Rutter C, Simon GP et al (2005) The association of comorbid depression with mortality in patients with type 2 diabetes. Diabetes Care 28(11):2668–2672

    Article  PubMed  Google Scholar 

  23. Ismail K, Winkley K, Stahl D et al (2007) A cohort study of people with diabetes and their first foot ulcer: the role of depression on mortality. Diabetes Care 30(6):1473–1479

    Article  PubMed  Google Scholar 

  24. Snoek FJ, Pouwer F, Welch GW, Polonsky WH (2000) Diabetes related emotional stress in Dutch and US diabetic patients: cross-cultural validity of the problem areas in diabetes scale. Diabetes Care 23:1305–1309

    Article  PubMed  CAS  Google Scholar 

  25. Gore M, Brandenburg NA, Dukes E et al (2005) Pain severity in diabetic peripheral neuropathy is associated with patient functioning, symptom levels of anxiety and depression and sleep. J Pain Symptom Manage 30(4):374–385

    Article  PubMed  Google Scholar 

  26. Hoffman DL, Sadosky A, Alvir J (2009) Cross-national burden of painful diabetic peripheral neuropathy in Asia, Latin America and the Middle East. Pain Pract 9(1):35–42

    Article  PubMed  Google Scholar 

  27. Krueger PM, Friedman EM (2009) Sleep duration in the United States: a cross-sectional population-based study. Am J Epidemiol 169(9):1052–1063

    Article  PubMed  Google Scholar 

  28. IDF Clinical Guidelines Task Force (2005) Global guidelines for type 2 diabetes. International Diabetes Federation, Brussels

  29. Kulzer B, Albus C, Herpertz S et al (2008) Psychosoziales und Diabetes. Diabetol Stoffw 3 (Suppl 2):168–174

    Article  Google Scholar 

  30. Hermanns N, Kulzer B, Krichbaum M et al (2006) How to screen for depression and emotional problems in patients with diabetes: comparison of screening characteristics of depression questionnaires, measurement of diabetes-specific emotional problems and standard clinical assessment. Diabetologia 49(3):469–477

    Article  PubMed  CAS  Google Scholar 

  31. Vileikyte L, Peyrot M, Bundy C et al (2003) The development and validation of a neuropathy- and foot ulcer-specific quality of life instrument. Diabetes Care 26(9):2549–2555

    Article  PubMed  Google Scholar 

  32. Hermanns N, Kulzer B, Stark S, Haak T (2007) NeuroQol: Ein effektives Instrument zum Neuropathiescreening. Diabetol Stoffw 2 (Suppl 1):S81

    Google Scholar 

  33. Viala-Danten M, Martin S, Guillemin I, Hays RD (2008) Evaluation of the reliability and validity of the Medical outcomes study sleep scale in patients with painful diabetic peripheral neuropathy during an international clinical trial. Health Qual Life Outcomes 6:113

    Article  PubMed  Google Scholar 

  34. Kulzer B, Krichbaum M, Hermanns N (2008) Diabetesschulung - was ist zeitgemäß, was ist gesichert? Diabetologe 4(5):337–347

    Article  Google Scholar 

  35. Kulzer B, Hermanns N, Maier B et al (2007) NEUROS: Ein neues Schulungs- und Behandlungsprogramm für Menschen mit Diabetes und Neuropathie. Kirchheim, Mainz

  36. Haslbeck M, Luft D, Neundörfer B et al (2008) Diabetische Neuropathie. Diabetol Stoffw 3 (Suppl 2):S134–S140

    Article  Google Scholar 

  37. Lustman PJ, Griffith LS, Freedland KE et al (1998) Cognitive behavior therapy for depression in type 2 diabetes: a rondomized controlled trial. Ann Intern Med 129:613–621

    PubMed  CAS  Google Scholar 

  38. Kroenke K, Blair MJ, Damush TM et al (2009) Optimized antidepressant therapy and pain selfmanagement in primary care patients with depression and muscoloskeletal pain: a randomized controlled trial. JAMA 301(20):2099–2110

    Article  PubMed  CAS  Google Scholar 

Download references

Interessenskonflikt

Der korrespondierende Autor weist auf folgende Beziehungen hin: Die Firma Lilly hat die Entwicklung des Schulungs- und Behandlungsprogramms „NEUROS“ unterstützt, dessen Erstautor Dr. Kulzer ist. Für die Umsetzungs-Workshops hat er von der Firma Lilly ein Referentenhonorar erhalten.

Author information

Authors and Affiliations

  1. Diabetes Zentrum Mergentheim, Forschungsinstitut Diabetes Akademie Bad Mergentheim (FIDAM), Theodor Klotzbücher Str. 12, 97980, Bad Mergentheim, Deutschland

    B. Kulzer & N. Hermanns

Authors
  1. B. Kulzer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. N. Hermanns
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to B. Kulzer.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kulzer, B., Hermanns, N. Depression, Angst und Schlafstörungen – wichtige Komorbiditäten der Neuropathie. Diabetologe 5, 350–359 (2009). https://doi.org/10.1007/s11428-009-0390-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11428-009-0390-4

Schlagwörter

Keywords

Search

Navigation